Additional Spanish hospital joining our clinical trial
November 8, 2022. Inossia has a steady enrolment pace in our multicenter clinical trial. We are now very pleased to add an additional Spanish hospital. Looking forward to valuable contributions from Dr. David Noriega, who is an important key opinion leader, and the rest of the team at Hospital de Medina del Campo in Valladolid, […]
EIT Health -Softbone project- meets in Madrid
November 2-3, 2022 – Inossia was in Madrid and had a meeting with the participants from the EIT Health project SOFTBONE. This is our European multicenter randomized clinical trial. The aim is to show a reduced amount of new and unnecessary spinal fractures when using our soft bone cement V-Flex compared to conventional bone cement. Learn more […]
Inossia adds a new country Poland to our medical trial
October 25, 2022. Inossia adds a new country, Poland, to our medical clinical trial of soft cement V-Flex. Medical University of Lodz will be a valuable contribution to the growing trial that is ongoing in Germany and Spain. We are happy to welcome Dr. Maciej Radek, Dr. Jakub Janowski and the rest of the team […]
Inossia at Eurospine 2022
October 19-21, 2022 – Inossia was in Milan, at the congress of EUROSPINE, the Spine Society of Europe, internationally recognized as the leading event in the world of spine. Together with our partner company G21 and other professionals, we had interesting discussions related to spine care treatments. V-Flex, a flexible bone cement for percutaneous vertebral augmentation […]
Inossia at North American Spine Society 2022
October 12-14, 2022 – Inossia was present at the North American Spine Society conference, NASS in Chicago. NASS is a premier multidisciplinary medical organization representing more than 7,000 members in 67 countries. Inossia and partner company G21 showcased and demonstrated V-Flex – A flexible bone cement for percutaneous vertebral augmentation procedures. Inossia also had the opportunity […]
Welcoming Hospital San Carlos in Madrid
October 10, 2022. Our multicenter randomized clinical trial of soft cement V-Flex, with the aim of including 150 patients in Europe, is growing. We are happy to welcome Dr. Rafael Luque Pérez and his team from hospital San Carlos in Madrid.
Inossia at NASS and Eurospine 2022
Inossia will be at NASS, October 12-15 in Chicago and Eurospine, October 19-21 in Milan.
Welcome Mårten Winge!
May 04, 2022. We are happy to introduce our latest board member Mårten Winge. Mårten has an extensive executive management and advisory experience from life science startups and growth companies. Currently he is the CEO of Strike Pharma AB in Uppsala. Mårten has a broad international business network.Warm welcome Mårten as a valuable member of […]
Inossia awarded a Vinnova, Swelife and Medtech4Healths grant
2022-03-29 Inossia is very happy to announce that we have been awarded a Vinnova, Swelife and Medtech4Healths grant in the call “Samverkansprojekt för bättre hälsa”. From a total of 94 contributions, only 14 were selected. Inossia will together with our partners at Akademiska sjukhuset and Stockholm School of Economics, evaluate the clinical outcomes and establish a road-to-market […]
Welcoming Krankenhaus Mechernich
March 17, 2022. We are happy to welcome a new center – Krankenhaus Mechernich – who has now joined our multicenter randomized clinical trial of soft cement V-Flex with the aim of including 150 patients in Europe. Dr. Robert Pflugmacher is joining Dr. David Eschman – UMM Universitätsmedizin Mannheim, Dr. Raquel Gutiérrez-González – Hospital Universitario […]
